by Ming Mui | Jul 10, 2025 | Market News, Medical Use, Pharmaceutical, Stock Market
Shares of ProKidney Corp (NASDAQ: PROK) soared more than 25% in Thursday afternoon trading after the company reported encouraging topline results from its Phase 2 REGEN-007 trial evaluating rilparencel in patients with chronic kidney disease (CKD) and diabetes. The...
by Lucas Shum | Jul 2, 2025 | Domestic, Economics, Healthcare, Market News, Medical Use, Stock Market
Healthcare stocks were hammered Tuesday after the Senate passed President Donald Trump’s sweeping “One Big Beautiful Bill,” sending shockwaves through the sector amid concerns over deep federal spending cuts and structural changes to public healthcare programs....
